Myocarditis is a complex disease because multiple pathogenetic mechanisms play a role. While these mechanisms appear to act in a chronological cascade, they undoubtedly overlap in some cases, rendering diagnosis and treatment difficult. Ultimately, dilated cardiomyopathy (DCM) may result. A multitude of still-circumstantial evidence points to a major role of viral myocarditis in the etiology of DCM. The common presence of viral genetic material and viral proteins in the myocardium of patients with DCM provides the most compelling evidence, but proof of causality is still lacking. Nevertheless, because of the striking increase in heart failure prevalence in recent years, anti-viral and anti-inflammatory therapies should be developed for their potential to prevent or ameliorate DCM.
. Introduction
initial insult to the myocardium occurs. This is believed, but certainly not proven, to be a viral infection in the great Myocarditis is, by definition, an inflammatory disorder, majority of cases, and other forms of injury may also while dilated cardiomyopathy (DCM) is, in most cases, trigger the triphasic cascade. In most patients overt congesidiopathic. However, accumulating data has revealed an tive heart failure does not occur during phase 1, and the important inflammatory component in the pathogenesis of initial insult may go unnoticed. After resolution of the DCM, and there is growing evidence that myocarditis and initial injury, the second phase develops as a result of DCM are closely related. The purpose of this review is to autoimmunity triggered by that injury. Clinically overt demonstrate the interrelationship between the two. This congestive heart failure often develops in this phase as a topic was authoritatively reviewed in 1999 by Kawai [1] .
result of extensive additional myocardial injury. In the By examining the pathogenesis of myocarditis we will third phase a typical picture of DCM develops and may consider mechanisms by which viral myocarditis might progress despite cessation of the first two processes. cause dilated cardiomyopathy. We will then review the basic and clinical evidence supporting the claim that myocarditis is a common precursor of DCM.
. Myocarditis: a triphasic disease
It is helpful to recognize myocarditis as a progressive Fig. 1 . Triphasic disease process. In its simplest form, myocarditis can be viewed as a chronological sequence of three pathogenetically distinct disease with three distinct, chronologically successive phases. Different diagnostic and therapeutic strategies are necessary in stages (Fig. 1 ). With these three distinct processes in mind, it is easier to consider diagnostic and therapeutic strategies. Clearly, these will differ for each stage of disease. In the initial phase, evidence of active viral infection will be the most useful finding. A history of recent chemical and toxin exposure may lead to a diagnosis. Therapy in this stage requires removal of the responsible agent. In the case of viral infection, antiviral therapies and support of the immune system may be helpful, though evidence from clinical trial is unavailable. Though there are relatively few relevant therapeutic options today, future possibilities are discussed below (see Section 5) .
The second phase of myocarditis has been targeted in most therapy trials to date [2] [3] [4] . These studies assumed dominance of autoimmunity as the etiology of ventricular dysfunction. Endomyocardial biopsy showing lymphocytic infiltration and other histological indicators of immune therapy tailored to the disease state and specific etiology.
In phase 3, after both the infectious and the autoimmune processes have abated, the disease takes on the characteristics of idiopathic dilated cardiomyopathy. Diagnosis is to substantiate this possibility for bacterial, fungal and made with the usual imaging methods and therapy is other infections. directed at prevention and reversal of adverse remodeling.
In animal models, and surely in humans, separation between the three phases is not always distinct. They may 3 . Multiple mechanisms of viral and immune injury overlap one another chronologically, and phases 1 or 2 may recur after the triphasic cascade has progressed, There is a stunning array of mechanisms by which resulting in multiple cycles of disease occurring simulcardiotropic viruses can cause congestive heart failure. taneously. Thus, the triphasic model is too simple in some These are listed in Table 1 . Myocytolysis by replicating cases to provide appropriate clinical guidance. It is very virus in the absence of a specific immune response is likely that the immunosuppression trials of the past [2] [3] [4] well-documented [9] in animal models. This phenomenon included patients in all three phases of myocarditis, which may play a role in fulminant myocarditis in humans, and could explain the failure of therapy to provide a detectable an effective immune response, without subsequent aubenefit.
toimmunity and viral persistence, may account for the high While this triphasic model is intended to describe viral recovery rate [10] . During phase 1 the immune response is myocarditis, at least one other infectious agent, a necessary path to recovery. This was demonstrated in the Trypanosoma cruzi, the protozoan responsible for Chagas' US myocarditis treatment trial [4] in which markers of an disease, induces an autoimmune phase of disease after the effective immune response, such as anti-cardiac IgG, initial injury which later leads to dilated cardiomyopathy correlated with a better outcome (Fig. 2) . However, the [5] [6] [7] . This three-stage process may be generalizable to immune response during phase 1 may add to the severity other cardiac infections [8] , but little work has been done of virus-induced injury by destroying or disabling virus- harboring myocytes. Binah recently reviewed the basic myocytes, in the absence of both replication and immune mechanisms by which cytotoxic T lymphocytes (CD41 activation, can cause atrial and ventricular dilatation and and CD81) may injure cells through the normal immune failure. response [11] . It appears that lymphocyte-derived perforins By virtue of the injury induced in earlier phases, viruses and serine esterases may be responsible for initiating may also worsen heart failure by prompting adverse apoptosis leading to death of targeted cells. In addition, the remodeling in phase 3. It is not clear if the remodeling Fas ligand / Fas receptor pathway may bring T-lymphocytes process itself is different when viral infection is the and myocytes together and cause ion channel disturbances initiating event, but the study of Wessely et al. suggests as well as apoptosis. Cytokines also contribute both to that it might be and that the possibility should be further recovery [12] from infection and to worsened cellular explored. injury [13, 14] during phase 1, as well as later phases. Increased levels of cytokines have been found in humans with myocarditis and dilated cardiomyopathy [15] . In a 4 . Inflammation and infection in dilated murine myocarditis model in which marked activation of cardiomyopathy tumor necrosis factor-alpha is present, administration of antibody directed at the cytokine reduced the severity of Investigators have speculated for decades on the possidisease [14] .
bility that myocarditis is a common forerunner of When T-cell and associated cytokine mechanisms fail to 'idiopathic' dilated cardiomyopathy. Table 2 lists several inactivate, myocarditis extends into phase 2. This extenlines of evidence supporting this speculation. Perhaps the sion may result, in part, from molecular mimicry [16] or first evidence favoring this possibility was presented by from virally-induced killer T cell activation [17] .
Orinius [22] , who found cardiac disease in humans many As noted above, humoral immune responses during years after apparently uncomplicated Coxsackievirus inphase 1 may improve outcome, but these responses may be fection. With the use of endomyocardial biopsy to prove harmful during phase 2. Cross reacting antibodies alone the presence of virus-associated myocardial inflammation may induce autoimmune myocarditis in animals [18] .
prior to therapy [23] , it became apparent that at least some Numerous cardiac autoantibodies have been detected in patients who ultimately developed typical dilated carpatients [19] , including antibodies to heart muscle comdiomyopathy did so as a result of myocarditis. Considerponents, such as anti-sarcolemmal antibody and antiable support for the hypothesis that myocarditis can lead to myosin alpha and beta heavy chains, antibodies against dilated cardiomyopathy is provided by the many murine mitochondrial proteins, such as the adenine nucleotide models of viral and other forms of myocarditis that translocator and, antibodies directed at membrane recepunequivocally progress to cardiac dilatation. However, tors such as the beta-1 receptor. Furthermore, the presence experimental and clinical studies focused on myocarditis of organ-specific cardiac antibodies in symptom-free relacannot inform us of the proportion of cases of DCM that tives of patients with dilated cardiomyopathy is predictive result from a preceding inflammatory insult in humans. of progression [19] .
Bowles et al., using a slot-blot hybridization technique The importance of latent or persistent virus in pathoon human endomyocardial biopsy tissue, provided the first genesis of heart failure in phases 2 and 3 is uncertain, but convincing evidence for viral presence in DCM [24] . not cover all potential viral pathogens. For example, no globulins from the plasma of patients with DCM improves early studies included primers for hepatitis C virus, which ventricular function [38, 39] . These studies strongly impliis now known to be present in relatively high frequency cate a causal role of persistent autoimmunity in DCM. [34] . In addition, the literature makes it clear that there is While the possible importance of humoral mechanism is large regional variability in prevalence of known viral raised by these therapy trials, in and of themselves, they do pathogens [28, 35] . Knowledge of regional and chronologinot directly implicate viruses in DCM. Recent studies help cal variations in viral prevalence should be incorporated create a potential link between virus and DCM through into the selection of PCR probes.
circulating autoantibodies. Cardiac specific myosin antiDespite this wealth of PCR and other evidence for viral bodies are present in a large proportion of patients with involvement, as pointed out by Weiss et al. early on [26] , DCM [40] [41] [42] [43] [44] [45] . Several investigators have shown recently presence of viral genomic material does not prove pathothat viral infections induce antibodies that cross-react with genesis. Weiss et al. showed that enteroviral RNA is also viral and myosin epitopes [46] [47] [48] . Thus, molecular present in a variety of other cardiac disorders and in mimicry resulting from viral infection could account for normal hearts. Many studies have used patients without the presence of antimyosin antibodies, which, in turn, are cardiac disease as controls. The presence of cardiac muscle capable of inducing autoimmune myocarditis resulting in disease may increase the likelihood of viral presence. For dilated cardiomyopathy. example, Andreoletti et al. [29] found viral genomic material in endomyocardial biopsies of 36% of patients with DCM and 33% of patients with coronary artery 5 . Current and future inflammation-based therapy disease, but in none of their 45 healthy heart controls. These findings reemphasize the fact that presence of viral Heart failure prevalence is increasing in the United nucleotides in the heart does not establish an etiologic link.
States [49, 50] and other countries. Idiopathic DCM acAs noted above, there are multiple mechanisms by counts for a large portion of the cases. The growing which persisting virus might induce DCM. Recent studies evidence for a major role of viral and other inflammatory have shed light on the incidence of active infection as mechanisms in DCM should prompt new efforts to control compared to latency. Andreoletti et al. found antigenomic those mechanisms, even before all the proof is in. An RNA in only three of 46 patients with PCR-positivity, appealing possibility to consider is widespread childhood suggesting that the incidence of active infection is low.
vaccination against the most common cardiotropic viruses However, only about half of their population had DCM, [51, 52] . Strong proof of a link between viral infection and while the others had chronic coronary disease. Fujioka et DCM, accounting for the majority of cases, will be needed al. [30] , on the other hand, reported the presence of before a vaccination program could be undertaken because negative RNA strands in seven of nine patients with PCR of its great expense and the need for societal and govpositivity from a group of 26 with DCM.
ernmental support. Other novel strategies must be pursued Deguchi et al. [36] made an interesting recent observain the meantime. tion on the physical location of enteroviral RNA in patients
The existence of a common receptor for enteroviruses with DCM. They studied myocardial tissue from 26 and adenoviruses [53] [54] [55] provides another opportunity for patients who underwent partial left ventriculectomy for preventive therapy. If the interaction between viruses and treatment of heart failure. In patients with positive PCR their cellular receptor could be prevented, or if the signals, both positive and negative RNA strands were intracellular signaling consequent to that interaction could found within myocardial lesions, localized to degenerating be altered, infection might not occur. Tyrosine kinase lck myocytes, inflammatory cells and endothelial cells by in p56 may be a convenient point of attack with a situ hybridization. This provides evidence for active viral pharmaceutical agent [56] . infection in some patients with end-stage dilated carNew therapies should also be directed at ameliorating diomyopathy.
disease after the viral pathogen has established itself. In the A point favoring causal involvement of virus in DCM is case of CMV infection, gancyclovir is a proven therapy the observation by several groups that viral presence [57] which is now being evaluated in a prospective trial confers a poor prognosis [30, 36, 37] . An alternate interpre- [58] . Certainly, plasmapheresis strategies should be further tation is that viruses gain access more readily to more documented. Use of hyperimmune globulin [59, 60] and of severely diseased myocardium.
immunosuppressive therapies [61] in patients with proven In aggregate, these PCR data must be interpreted with immune activation should be further evaluated. Ancaution because a pathogenetic role of latent or replicating ticytokines [12, 14, 62] , T-cell receptor vaccines [63] 
